The long-term use of aspirin has been shown to significantly reduce the incidence of digestive cancers, new research presented at the 25th UEG (United European Gastroenterology) Week has found.
Tag Archives: aspirin
As a daily consumer of aspirin for the arthritis in my hands, I was pleased to run across this new study from Cardiff University on the drug’s benefits.
Stomach bleeds caused by aspirin are considerably less serious than the spontaneous bleeds that can occur in people not taking the drug, concludes a study led by Cardiff University.
Published in the journal Public Library of Science, the extensive study of literature on aspirin reveals that while regular use of the drug increases the risk of stomach bleeds by about a half, there is no valid evidence that any of these bleeds are fatal.
Professor Peter Elwood from Cardiff University’s School of Medicine said: “Although many people use aspirin daily to reduce the risk of health problems such as cancer and heart disease, the wider use of the drug is severely limited because of the side effect of bleeding from the stomach…”
“With our study showing that there is no increased risk of death from stomach bleeding in people who take regular aspirin, we hope there will be better confidence in the drug and wider use of it by older people, leading to important reductions in deaths and disablement from heart disease and cancer across the community.”
Professor Peter Elwood, School of Medicine
Heart disease and cancer are the leading causes of death and disability across the world, and research has shown that a small daily dose of aspirin can reduce the occurrence of both diseases by around 20-30%.
Recent research has also shown that low-doses of aspirin given to patients with cancer, alongside chemotherapy and/or radiotherapy, is an effective additional treatment, reducing the deaths of patients with bowel, and possibly other cancers, by a further 15%.
The study ‘Systematic review and meta-analysis of randomized trials to ascertain fatal gastrointestinal bleeding events attributable to preventive low-dose aspirin: No evidence of increased risk’ can be found in Public Library of Science.
It makes sense for people at high risk of heart problems to take aspirin, he concluded.
“For all those people, they should take aspirin for the long haul, because the benefits outweigh the risk,” Gaziano said. “But if you’re very low risk, the benefits of aspirin likely don’t outweigh the risk” of increased bleeding.
Daily low-dose aspirin therapy may not have significant heart-health benefits for older people, new research suggests.
The study, which involved more than 14,000 Japanese people aged 60 to 85, found no major difference in heart-related deaths or non-fatal heart attacks and strokes between people who took aspirin and those who didn’t.
“It indicates that primary prevention with daily low-dose aspirin does not reduce the combined risk in this population,” said study co-author Dr. Kazuyuki Shimada, of the University of Shin-Oyama City Hospital in Tochigi, Japan.
Despite this study’s findings, people should talk with their doctor before they stop taking aspirin to prevent heart attacks and strokes, said Dr. Michael Gaziano, chief of the division of aging at Brigham and Women’s Hospital in Boston and a professor at Harvard Medical School.
“Patients need to discuss this with their doctor, because I think it’s difficult to do that calculation of benefit and…
View original post 458 more words
“We estimate that individuals with significant plaque buildup in the arteries of the heart are much more likely to prevent a heart attack with aspirin use than to suffer a significant bleed” explains Miedema. “On the opposite end of the spectrum, if you don’t have any calcified plaque, our estimations indicate that use of aspirin would result in more harm than good, even if you have risk factors for heart disease such as high cholesterol or a family history of the disease.”
Cardiac Screening Test May Help Determine Who Should Take Aspirin to Prevent Heart Attack
A study involving the Minneapolis Heart Institute Foundation shows that a simple test to measure plaque in the arteries of the heart may help doctors better determine who will and will not benefit from use of aspirin therapy to prevent heart disease.
For over 30 years, aspirin has been known to prevent heart attacks and strokes, but who exactly should take a daily aspirin remains unclear. New research published today in Circulation: Cardiovascular Quality and Outcomes shows that your coronary artery calcium (CAC) score, a measurement of plaque in the arteries that feed the heart, may help determine whether or not you are a good candidate for aspirin.
“Many heart attacks and strokes occur in individuals who do not appear to be at high risk,” states lead author, Michael D Miedema, MD, MPH. “Individuals with known…
View original post 558 more words
I have been hearing for years how taking aspirin daily would prevent this or that type of cancer. I admit to confusion on the issue. There always seemed to be new qualifiers to the statement. So, I was thrilled to see an interview with Eric J. Jacobs, Ph.D., American Cancer Society (ACS) Researcher on the ACS website.
A. Yes, there is now definitive evidence that long-term daily aspirin use, even at low doses, will lower risk of developing one type of cancer – colorectal cancer, probably by approximately 40%. However, this benefit is unlikely to “kick in” immediately. There appears to be a delay of several years between when aspirin use is started and when risk of developing colorectal cancer is reduced. Continue reading